Inventor · disambiguated record
Marcus Bauser
Also filed as: BAUSER MARCUS · MIGLARESE MARK
19 granted patents·9 pending applications·128 citations·filing 2000–2018
93Inventor score
Files withBAYER HEALTHCARE AG6Bayer Pharma AG6AICURIS GMBH & CO KG2ALLERHEILIGEN SWEN2BAYER IP GMBH2
Top patents by PatentIndex Score
28 records- 0188US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 0288US7135486B1Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereofBAYER AG·Filed 2000·Granted Nov 14, 2006·35 cites·17 claims
- 0387US7776922B2Substituted [(phenylethanoyl)amino]benzamidesBAYER SCHERING PHARMA AG·Filed 2005·Granted Aug 17, 2010·16 cites·7 claims
- 0486US9951027B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Apr 24, 2018·8 cites·22 claims
- 0585US10138226B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·6 cites·29 claims
- 0680US6936609B2Imidazotriazines for use as phosphodiesterase inhibitorsBAYER HEALTHCARE AG·Filed 2002·Granted Aug 30, 2005·17 cites·7 claims
- 0780US6930114B2Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 16, 2005·19 cites·8 claims
- 0879US10137110B21-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·29 claims
- 0979US8198267B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jun 12, 2012·7 cites·8 claims
- 1078US7504421B2Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their useROSENTRETER ULRICH·Filed 2006·Granted Mar 17, 2009·4 cites·13 claims
- 1173US8314089B2Substituted pyrazolamides and their useSCHOHE-LOOP RUDOLF·Filed 2010·Granted Nov 20, 2012·3 cites·11 claims
- 1271US8383822B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2008·Granted Feb 26, 2013·1 cites·11 claims
- 1353US8487111B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jul 16, 2013·0 cites·8 claims
- 1451US10442772B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 1549US8846934B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2013·Granted Sep 30, 2014·0 cites·9 claims
- 1648US2010022527A1Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseasesAICURIS GMBH & CO KG·Filed 2009·Application pending·0 cites
- 1746US2008249105A1Pyrrolopyridine-Substituted Benzol Derivatives for Treating Cardiovascular DiseasesBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 1845US7867992B2Substituted quinolonesAICURIS GMBH & CO KG·Filed 2007·Granted Jan 11, 2011·0 cites·16 claims
- 1945US2010105673A1Substituted aminofuranones and their useBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 2043US8263624B2Aryl-substituted heterocycles, and use thereofHAERTER MICHAEL·Filed 2007·Granted Sep 11, 2012·0 cites·14 claims
- 2142US2008194598A1Pyrimidine Carboxylic Acid Derivatives and Use ThereofBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 2242US2006247303A17H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereofBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
- 2341US2008214654A1Substituted Benzyloxy-Phenylmethylamide DerivativesBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 2440US2008261990A1Novel Pyrimidine Derivatives and their UseBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 2538US8097629B2Dihydropyridinone derivativesGIELEN-HAERTWIG HEIKE·Filed 2005·Granted Jan 17, 2012·0 cites·4 claims
- 2638US2003236276A1Pyrrolo[2.1-a]isoquinoline derivativesFiled 2002·Application pending·0 cites
- 2737US2003187028A1Medicament for viral diseasesFiled 2001·Application pending·0 cites
- 2830US9884063B2Amido-substituted azole compoundsBayer Pharma AG·Filed 2015·Granted Feb 6, 2018·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Marcus Bauser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →